These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24192846)

  • 41. Impact of miscuffing during home blood pressure measurement on the prevalence of masked hypertension.
    Mourad JJ; Lopez-Sublet M; Aoun-Bahous S; Villeneuve F; Jaboureck O; Dourmap-Collas C; Denolle T; Fourcade J; Baguet JP
    Am J Hypertens; 2013 Oct; 26(10):1205-9. PubMed ID: 23727841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Women with prehypertension in primary care - Risk profile on the basis of selected cardiovascular risk factors.
    Gryglewska B; Sulicka J; Fornal M; Wizner B; Cwynar M; Grodzicki T
    Blood Press; 2009; 18(3):99-104. PubMed ID: 19391053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults.
    Yu D; Huang J; Hu D; Chen J; Cao J; Li J; Gu D
    J Cardiovasc Pharmacol; 2009 May; 53(5):388-400. PubMed ID: 19454899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study.
    Shimbo D; Newman JD; Schwartz JE
    Am J Hypertens; 2012 Jun; 25(6):664-71. PubMed ID: 22378035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
    Afsar B
    J Cardiol; 2013 Mar; 61(3):222-6. PubMed ID: 23294898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Masked hypertension: evaluation, prognosis, and treatment.
    Angeli F; Reboldi G; Verdecchia P
    Am J Hypertens; 2010 Sep; 23(9):941-8. PubMed ID: 20508623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of cardiovascular risk factors in men with stable coronary heart disease in France and Spain.
    Grau M; Bongard V; Fito M; Ruidavets JB; Sala J; Taraszkiewicz D; Masia R; Galinier M; Subirana I; Carrié D; Vila J; Marrugat J; Ferrières J;
    Arch Cardiovasc Dis; 2010 Feb; 103(2):80-9. PubMed ID: 20226427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Masked hypertension: a review.
    Pickering TG; Eguchi K; Kario K
    Hypertens Res; 2007 Jun; 30(6):479-88. PubMed ID: 17664850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study.
    Terawaki H; Metoki H; Nakayama M; Ohkubo T; Kikuya M; Asayama K; Inoue R; Hoshi H; Ito S; Imai Y
    Hypertens Res; 2008 Dec; 31(12):2129-35. PubMed ID: 19139602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Masked Hypertension: A Systematic Review.
    Thakkar HV; Pope A; Anpalahan M
    Heart Lung Circ; 2020 Jan; 29(1):102-111. PubMed ID: 31477513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Masked hypertension and effort-reward imbalance at work among 2369 white-collar workers.
    Boucher P; Gilbert-Ouimet M; Trudel X; Duchaine CS; Milot A; Brisson C
    J Hum Hypertens; 2017 Oct; 31(10):620-626. PubMed ID: 28639611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of cardiovascular risk factors among healthcare staff in a large healthcare institution in Singapore.
    Leong L; Chia SE
    Singapore Med J; 2012 Aug; 53(8):517-21. PubMed ID: 22941128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Masked hypertension incidence and risk factors in a prospective cohort study.
    Trudel X; Brisson C; Gilbert-Ouimet M; Duchaine CS; Dalens V; Talbot D; Milot A
    Eur J Prev Cardiol; 2019 Feb; 26(3):231-237. PubMed ID: 30256672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and clustering of cardiovascular risk factors among healthy adults in a Chinese population: the MJ Health Screening Center Study in Taiwan.
    Wu DM; Pai L; Chu NF; Sung PK; Lee MS; Tsai JT; Hsu LL; Lee MC; Sun CA
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1189-95. PubMed ID: 11477504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and determinants of masked hypertension among obese individuals at the Yaoundé Central Hospital: a cross-sectional study in sub-Saharan Africa.
    Hamadou B; Amougou SN; Tchuendem Y; Nganou-Gnindjio CN; Mfeukeu-Kuate L; Foka AJ; Tankeu AT; Jingi AM; Menanga AP; Kingue S
    Blood Press Monit; 2020 Aug; 25(4):212-215. PubMed ID: 32541260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients.
    Leitão CB; Canani LH; Kramer CK; Boza JC; Pinotti AF; Gross JL
    Diabetes Care; 2007 May; 30(5):1255-60. PubMed ID: 17303786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group.
    Joffres MR; Hamet P; Rabkin SW; Gelskey D; Hogan K; Fodor G
    CMAJ; 1992 Jun; 146(11):1997-2005. PubMed ID: 1596849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimada K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.